Edition:
United Kingdom

Arcturus Therapeutics Ltd (ARCT.OQ)

ARCT.OQ on NASDAQ Stock Exchange Global Market

6.07USD
9:00pm BST
Change (% chg)

$-0.28 (-4.41%)
Prev Close
$6.35
Open
$6.34
Day's High
$6.69
Day's Low
$6.07
Volume
4,630
Avg. Vol
12,058
52-wk High
$10.00
52-wk Low
$4.11

About

Arcturus Therapeutics Ltd. is a ribonucleic acid (RNA) medicines company. The Company owns Lipid-enabled and Unlocked Nucleomonomer Agent modified RNA (LUNAR) lipid-mediated delivery and Unlocked Nucleomonomer Agent (UNA) technology, including UNA Oligomers. The Company’s diverse pipeline of RNA therapeutics includes programs... (more)

Overall

Beta: 1.99
Market Cap(Mil.): $68.34
Shares Outstanding(Mil.): 10.76
Dividend: --
Yield (%): --

Financials

  ARCT.OQ Industry Sector
P/E (TTM): -- 103.12 37.45
EPS (TTM): -2.19 -- --
ROI: -- 7.69 12.16
ROE: -- 8.19 16.93

Earnings vs. Estimates